TVTX Travere Therapeutics, Inc. logo

TVTX Travere Therapeutics, Inc.

Healthcare
$44.29-0.32%ClosedMarket Cap: $4.12B

As of 2026-05-26

Insider Statistics (Q2 2026)

Acquisitions

57

Dispositions

63

Buy/Sell Ratio

0.90

Net Shares

-11,765

Shares Acquired

653,000

Shares Disposed

664,765

Total Bought ($)

$0.00

Total Sold ($)

$38.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Thu May 21Williams Brinkley RuthdirectorSell12,000$42.2612,000
Thu May 21Williams Brinkley RuthdirectorSell4,000$0.0029,750
Thu May 21Squarer RondirectorSell12,000$42.2612,000
Thu May 21Squarer RondirectorSell4,000$0.0039,375
Thu May 21Poole SandradirectorSell12,000$42.2612,000
Thu May 21Poole SandradirectorSell4,000$0.0034,000
Thu May 21Orwin John AdirectorSell12,000$42.2612,000
Thu May 21Orwin John AdirectorSell4,000$0.0039,375
Thu May 21Meckler Jeffrey AdirectorSell12,000$42.2612,000
Thu May 21Meckler Jeffrey AdirectorSell4,000$0.0091,500
Tue May 19Coughlin TimothydirectorSell3,250$43.4952,250
Wed May 06ROTE WILLIAM E.officer: Chief Research OfficerSell2,763$43.95115,474
Wed May 06ROTE WILLIAM E.officer: Chief Research OfficerSell4,250$0.00118,237
Wed May 06ROTE WILLIAM E.officer: Chief Research OfficerSell8,500$0.008,500
Wed May 06Meckler Jeffrey AdirectorSell8,000$45.0087,500